General Meeting 2001 - Orlando, Florida

We have added this up-to-date information for those who will be attending the 2001 Annual General Meeting in beautiful, sunny Orlando Florrida.  If you are not attending the conference, you may be interested to see what the Division Officers have planned.  In addition to the symposia and poster sessions, the Public Health Division (Y) will hold the annual business meeting and a social "mixer" at dates and times to be announced.  Watch this page and subscribe to the Division Y list serv for up-to-the-minute updates.  If you have other questions about the meeting schedule or wish to build an itinerary for the meeting over the web, check the ASM national site here.  See you in Orlando!
 

Annual Business Meeting
Tuesday May 22, 12:00-1:00pm, Room 300.  Catered lunch provided by Kimberly-Clark. An excellent opportunity to get involved in your Division!

Tentative Agenda:
I. Introduction of Officers
II. Nominating Committee - Charge
III. Awards Committee - Formation
IV. Student Awards (Support for Travel to Annual Meeting)
V. Website/Listserve Information
VI. Fundraising
VII. Other Agenda Items

Social Mixer
We will  be co-hosting a social mixer with Division F on Monday evening from 7 - 9PM Signature 1, Rosen Centre Hotel.
 

Symposia
 

	New Developments in Vaccine Preventable Disease Session Number: 18/Y Session Time:    5/21/2001 8:00:00 AM - 10:30:00 AM Location: 311G CEÝHours: 2.5 Description:  Development of vaccines to a wide variety of infectious agents have contributed greatly to the improvement of the publicís health. This session brings together a diverse group of speakers that will address a variety of topics surrounding vaccine use including ethics as well as the technical aspects of vaccine development. Topics for discussion include recent improvements in vaccine delivery and advances in vaccine development for malaria, the human immunodeficiency virus infection, and for meningogococcal disease. Information provided in this session will be of value to laboratorians and epidemiologists. Presentations:  Alison C. Mawle-- Convener Myron M. Levine-- Convener Stephen L. Hoffman-- Towards a Vaccine for Malaria Reno Rappuoli-- A Meningococcal Conjugate Vaccine for Africa William J. Bellini-- Molecular Epidemiology of Measles: A Necessity for Control and Elimination MyronÝ M. Levine-- Oral Vaccines Seth Berkley-- Ethical Issues Surrounding a Vaccine for AIDS
	Emerging Pathogens - 2001 Session Number: 117/Y Session Start: 5/22/2001 8:00:00 AM - 10:30:00 AM Location: 311A-D CE Hours: 2.5 Description: Emerging pathogens are being increasingly recognized and associated with infectious diseases. In this session, speakers will address the epidemiology and the microbiology of agents associated with emerging diseases. Objectives of the symposium are to: * discuss and update the epidemiology of new agents * identify factors contributing to emergence * understand the factors contributing to spread of disease * highlight recent advances in laboratory diagnosis This symposium is designated for clinical and public health microbiologists, physicians, epidemiologists, veterinarians, infectious disease specialists and others with interest in emerging infectious agents. Presentations:  Stephen M. Ostroff-- Convener Mary J. Gilchrist-- Convener Duane J. Gubler-- Division Y Lecture: West Nile Virus Marc A. Fischer-- Toxin-Mediated Clostridial Sepsis Among Drug Injectors J Stephen Dumler-- Ecological and Microbial Influences on the Emergence of Ehrlishioses Linda A. Detwiler-- Animal Transmissible Spongiform Encephalopathy in the U.S. Stephen M. Ostroff-- Recent Encounters with Emerging Pathogens/Diseases
	Public Health Issues with Susceptibility Testing Session Number: 191/Y Session Start: 5/22/2001 2:30:00 PM - 5:00:00 PM Location: 311E CE Hours: 2.5 Description: This session will focus on the role of the public health laboratory in addressing the important issues of antimicrobic resistance. The speakers will discuss susceptibility testing of bacterial agents such as Staphylococuss aureus, Streptococcus pneumoniae and Mycobacterium spp. as well as the role of the public health laboratory in the determination of antiretroviral resistance in the human immmunodeficiency virus. The respective roles of the public health and hospital/independent laboratories will be addressed. Attendees with background in clinical and public health microbiology will benefit from these presentations. Presentations:  Barbara E. Robinson-Dunn-- Convener Fred C. Tenover-- Convener Gail L. Woods-- Susceptibility Testing of Non-Tuberculous Mycobacteria in the Public Health Setting Barbara E. Robinson-Dunn-- The Public Health Laboratory's Role in the Detection of Emerging Antimicrobial Resistance Bereneice M. Madison-- M. tuberculosis Susceptibility Testing: Problems, Practices and Proficiency Fred C. Tenover-- Emerging Staphylococcal and Pneumococcal Resistance: Two Different Federal Responses Stephen Day-- The Role of the Public Health Laboratory in Determining Resistance of the Human Immunodeficiency Virus to Antiviral Agents

 
 

Poster Session